Results of combined-modality therapy for
β
Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A
π
Article
π
2005
π
John Wiley and Sons
π
English
β 106 KB
π 2 views
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceβdaily radiotherapy (BIDRT) or onceβdaily radiotherapy (QDRT) resulted in a better outcome for patients with limitedβst